Lymphocyte Telomere Length Predicts Clinical Outcomes of HPV-Positive Oropharyngeal Cancer Patients after Definitive Radiotherapy.

dc.contributor.author

Luo, Xiaoning

dc.contributor.author

Sturgis, Erich M

dc.contributor.author

Yang, Zheng

dc.contributor.author

Sun, Yan

dc.contributor.author

Wei, Peng

dc.contributor.author

Liu, Zhensheng

dc.contributor.author

Wei, Qingyi

dc.contributor.author

Li, Guojun

dc.date.accessioned

2019-05-01T18:13:48Z

dc.date.available

2019-05-01T18:13:48Z

dc.date.issued

2019-02-05

dc.date.updated

2019-05-01T18:13:47Z

dc.description.abstract

Since lymphocyte telomere length (LTL) plays critical roles in the maintenance of genomic stability and integrity, LTL thus may influence the etiology and prognosis of squamous cell carcinoma of the oropharynx (SCCOP). However, given the association between LTL and risk of HPV-associated SCCOP and between LTL and tumor HPV status of SCCOP, we hypothesized that LTL is associated with SCCOP prognosis, particularly in HPV-positive patients after definitive radiotherapy. LTL and tumor HPV type 16 (HPV16) status were determined in 564 incident SCCOP patients before radiotherapy or chemoradiation. Both univariate and multivariable Cox regression analyses were performed to estimate the association between LTL and prognosis. Eighty-five percent of the patients had HPV16-positive tumors. Patients with shorter telomeres had significantly better overall, disease-specific, and disease-free survival than did those with longer telomeres (log-rank p < 0.001). Moreover, patients with shorter telomeres had significantly lower risk of death overall (hazard ratio [HR], 0.2; 95% confidence interval [CI], 0.1-0.4), death due to SCCOP (HR, 0.2; 95% CI, 0.1-0.4), and SCCOP recurrence (HR, 0.3; 95% CI, 0.2-0.5) after adjusting for other important prognostic confounders. Finally, we found more pronounced effects of LTL on survival in HPV16-positive SCCOP patients after stratified analysis according to tumor HPV status. These findings indicate that LTL plays a significant role in the survival of patients with SCCOP, especially HPV16-positive patients who undergo definitive radiotherapy. Therefore, pretreatment LTL may be an independent prognostic biomarker for HPV16-positive SCCOP. Prospective studies with larger sample sizes are needed to confirm these findings.

dc.identifier

5306965

dc.identifier.issn

0143-3334

dc.identifier.issn

1460-2180

dc.identifier.uri

https://hdl.handle.net/10161/18496

dc.language

eng

dc.publisher

Oxford University Press (OUP)

dc.relation.ispartof

Carcinogenesis

dc.relation.isversionof

10.1093/carcin/bgz019

dc.title

Lymphocyte Telomere Length Predicts Clinical Outcomes of HPV-Positive Oropharyngeal Cancer Patients after Definitive Radiotherapy.

dc.type

Journal article

duke.contributor.orcid

Wei, Qingyi|0000-0002-3845-9445|0000-0003-4115-4439

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Medicine, Medical Oncology

pubs.organisational-group

Medicine

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
LuoX-Telomere-HPV-OPCC-Survival-Cancino-LiG-2019.pdf
Size:
388.85 KB
Format:
Adobe Portable Document Format
Description:
Published version